Kathleen Wyne is an Endocrinology/Metabolic physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 131 publications with 11,502 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
543 Taylor Ave Fl 2
Columbus, OH 432031278
Telephone
614-685-3333Provider last certified this registry record 3 Mar 2025.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments$12,595openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20252 payments
- Madrigal PharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
61.9%Insulin Analog46.7%Fiasp Flextouch23%Tresiba Flextouch U-10019%Lantus Solostar16%Novolog Flexpen9%Basaglar Kwikpen U-1006%Insulin Lispro Kwikpen U-1005%Insulin Lispro4%Novolog4%Humalog Kwikpen U-1004%Humalog3%Fiasp3%Tresiba Flextouch U-2003%Part D<11 patientsGLP-1 receptor agonist7.8%Trulicity79%Ozempic21%Part D<11 patients+ 3 more classes in this area
Cardiovascular
25.9%Statin17.8%Rosuvastatin Calcium42%Atorvastatin Calcium33%Pravastatin Sodium25%Part D≥21 patientsACE inhibitor5.3%Lisinopril100%Part D≥11 patients+ 2 more classes in this area
Hormonal (systemic)
10.8%l-Thyroxine9.2%Levothyroxine Sodium66%Synthroid34%Part D<11 patientsAntihypoglycemic Agent1.6%Baqsimi100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes
Journal of Diabetes Science and Technology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
John Kissel, MD
The Ohio State University Wexner Medical Center
Douglas Scharre, MD
The Ohio State University Wexner Medical Center
Kathleen Dungan, MD
The Ohio State University Wexner Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”